Upcoming Allied Market Research
Constipation Treatment Market

Constipation Treatment Market

- Global Opportunity Analysis and Industry Forecast, 2022-2029

Report Code: A08195
Pages: NA
Nov 2022 | 1264 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Constipation Treatment Market

Request Now !

Constipation is a chronic disorder which causes abnormal bowel movements and results in hardened feces which persists for several weeks or even longer. It is defined medically as fewer than three stools per week and severe constipation as less than one stool per week. It causes infrequent stools, difficult stool passage with pain and stiffness. Acute constipation may cause blocking of the intestine, which may even require surgical intervention. The symptoms of constipation include bloating, lower abdominal discomfort, rectal bleeding, anal fissures caused by hard stools, incomplete evacuation, gastric pain, and strain during the bowel movement. Being an idiopathic condition, there is uncertainty regarding the causes of this disease. However, the two disorders that cause constipation are pelvic floor dysfunction, and colonic inertia. There are many causes of and associations with constipation including dehydration, side effects of certain medications, low fiber diets, hormonal disorders and high levels of estrogen and progesterone during pregnancy.


Chronic idiopathic constipation (CIC) is a severe form of constipation and it is a gastrointestinal disorder which leads to discomfort while defecating. It is often seen in geriatric populations especially adults. Diagnosis of chronic idiopathic constipation is tedious due to the dearth of physiological evidences and physicians try to diagnose the condition by evaluating parameters like weight, blood in stool, and low blood count.

COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to chondroitin sulfate has been reduced and this segment have to face negligence subsequently causing negative impact on constipation treatment market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The factors such as rising expenditure in R&D activities for the developments of innovative drugs, developments in healthcare infrastructure, rise in the aged and geriatric population, sedentary lifestyle, changing dietary habits, and inadequate consumption of fast food in high quantity, frequently are leading to rise in demand for constipation treatment market growth in coming years.
Along with the growing complexity in the healthcare domain there is need to provide better treatment and solutions to the upcoming challenges. Presence of healthcare professionals with optimum knowledge and expertise, high prevalence IBS, chronic constipation and the development of latest drugs and treatment procedures and advancements associated with gastrological mechanisms have revolutionized the growth of constipation treatment market. The irritable bowel syndrome (IBS) is a chronic, recurring gastrointestinal tract disorder that is found affecting between 7%–18% of the population worldwide. Treatment of IBS currently is a multifaceted approach, as a direct single approach therapy hasn’t been effective so far. Hence, the multi approach therapy is a combination therapy consisting of changes in diet, exercise, stress management, and medication. Efforts are being made and various key players are engaged in R&D activities associated with getting a direct breakthrough treatment for IBS and chronic constipation which creates lucrative opportunities in the market.

Recent developments and innovations to boost the growth rate

The prime objective of constipation treatment is to normalize the frequency and quantity of stool in order to promote normal defecation. Heavy investments in R&D and numerous studies on pharmacologic and non-pharmacologic treatments for constipation proven successful in terms of overcoming some of the challenges like temporary status and efficacy and comparatively are better than their predecessors who have shown mediocre performance and lack of efficacy.  However, the latest innovations such as enterokinetic agents and intestinal secretagogues have shown positive outcomes being capable in delivering high efficacies and low incidences of adverse events. Research on biofeedback and surgical treatment have proved efficient as well as better quality of life for patients with refractory constipation. These factors would boost the market for constipation treatment. For instance, Astellas Pharma, Inc. in working on a novel drug and submitted new drug application for Linaclotide for patients with chronic constipation in Japan. Similarly in January 2017, FDA announced approval for the Linzess manufactured by Allergan Plc. and Ironwood Pharmaceuticals and Tulane manufactured by Synergy Pharmaceuticals for the treatment of chronic idiopathic constipation 

Emerging Economies Opening New Opportunities for Market 

Constipation is a common disorder experienced by every individual and is evident in 8% to 32.5% of population worldwide. Increasing geriatric population, sedentary lifestyle and changing dietary habits in developed as well upcoming economies and thus creating lucrative markets, especially the unexplored markets in the developing economies is expected to increase the demand for constipation treatment across the globe in the near future. More than 50% of the people belonging to age group above 50 years of age are prone suffer chronic constipation. The average prevalence of constipation in adults has been around 16% worldwide; whereas 33.5% prevalence was seen in adults aged 60 to 110 years. There is high prevalence of irritable bowel syndrome in emerging markets such as Asia Pacific and Latin America which would lead to tremendous growth of market in coming years.

Key benefits of the report:

  • This study presents the analytical depiction of the global constipation treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global constipation treatment market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global constipation treatment market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global constipation treatment market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Constipation Treatment Market research report:

  • Who are the leading market players active in the constipation treatment market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the constipation treatment market?
  • What are the projections for the future that will help in taking further strategic steps?

Constipation Treatment Market Report Highlights

Aspects Details
By Therapeutics
  • Laxatives
  • Chloride channel activators
  • Peripherally Acting Mu-Opioid Receptor Antagonists
  • GC-C Agonists
  • 5-HT4 Receptor Agonists
By Disease Type
  • Chronic idiopathic constipation (CIC)
  • Opioid-induced constipation (OIC)
  • Irritable bowel syndrome with constipation (IBS-C)
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players AstraZeneca plc, Takeda Pharmaceutical Company Limited, Abbott Laboratories, Valeant Pharmaceuticals International Inc., Bayer AG, Pfizer Inc., Sanofi, Synergy Pharmaceuticals, Inc., Janssen Pharmaceutical Company, Boehringer Ingelheim GmbH, Ironwood Pharmaceuticals.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Constipation Treatment Market

Start reading.
This Report and over 19,267+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers